BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 15885100)

  • 1. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts.
    Blero D; Zhang J; Pesesse X; Payrastre B; Dumont JE; Schurmans S; Erneux C
    FEBS J; 2005 May; 272(10):2512-22. PubMed ID: 15885100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHIP2 controls PtdIns(3,4,5)P(3) levels and PKB activity in response to oxidative stress.
    Zhang J; Liu Z; Rasschaert J; Blero D; Deneubourg L; Schurmans S; Erneux C; Pesesse X
    Cell Signal; 2007 Oct; 19(10):2194-200. PubMed ID: 17643961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity.
    Vandeput F; Backers K; Villeret V; Pesesse X; Erneux C
    Cell Signal; 2006 Dec; 18(12):2193-9. PubMed ID: 16824732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.
    Giuriato S; Pesesse X; Bodin S; Sasaki T; Viala C; Marion E; Penninger J; Schurmans S; Erneux C; Payrastre B
    Biochem J; 2003 Nov; 376(Pt 1):199-207. PubMed ID: 12885297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
    Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P₃ level, a positive control of PtdIns(3,4)P₂ production, and intrinsic docking properties.
    Erneux C; Edimo WE; Deneubourg L; Pirson I
    J Cell Biochem; 2011 Sep; 112(9):2203-9. PubMed ID: 21503961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes.
    Tang X; Powelka AM; Soriano NA; Czech MP; Guilherme A
    J Biol Chem; 2005 Jun; 280(23):22523-9. PubMed ID: 15824124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoinositide phosphatases: just as important as the kinases.
    Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA
    Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners.
    Onnockx S; De Schutter J; Blockmans M; Xie J; Jacobs C; Vanderwinden JM; Erneux C; Pirson I
    J Cell Physiol; 2008 Jan; 214(1):260-72. PubMed ID: 17620296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.
    Mandl A; Sarkes D; Carricaburu V; Jung V; Rameh L
    Mol Cell Biol; 2007 Dec; 27(23):8098-112. PubMed ID: 17893321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2.
    Dyson JM; Kong AM; Wiradjaja F; Astle MV; Gurung R; Mitchell CA
    Int J Biochem Cell Biol; 2005 Nov; 37(11):2260-5. PubMed ID: 15964236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity.
    Pesesse X; Moreau C; Drayer AL; Woscholski R; Parker P; Erneux C
    FEBS Lett; 1998 Oct; 437(3):301-3. PubMed ID: 9824312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1.
    Nishio M; Watanabe K; Sasaki J; Taya C; Takasuga S; Iizuka R; Balla T; Yamazaki M; Watanabe H; Itoh R; Kuroda S; Horie Y; Förster I; Mak TW; Yonekawa H; Penninger JM; Kanaho Y; Suzuki A; Sasaki T
    Nat Cell Biol; 2007 Jan; 9(1):36-44. PubMed ID: 17173042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
    J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of PDGF-stimulated SHIP2 tyrosine phosphorylation and association with Shc in 3T3-L1 preadipocytes.
    Artemenko Y; Gagnon A; Ibrahim S; Sorisky A
    J Cell Physiol; 2007 Jun; 211(3):598-607. PubMed ID: 17219406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin.
    Blero D; De Smedt F; Pesesse X; Paternotte N; Moreau C; Payrastre B; Erneux C
    Biochem Biophys Res Commun; 2001 Apr; 282(3):839-43. PubMed ID: 11401540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic switching of PI3K-dependent lipid signals.
    Downes CP; Leslie NR; Batty IH; van der Kaay J
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):188-92. PubMed ID: 17371235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
    Maehama T; Dixon JE
    J Biol Chem; 1998 May; 273(22):13375-8. PubMed ID: 9593664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5'-phosphatase interaction with c-Abl.
    Mokhtari D; Al-Amin A; Turpaev K; Li T; Idevall-Hagren O; Li J; Wuttke A; Fred RG; Ravassard P; Scharfmann R; Tengholm A; Welsh N
    Diabetologia; 2013 Jun; 56(6):1327-38. PubMed ID: 23462796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.